Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 14Neoplasms 4Lung Neoplasms 4Advanced Solid Tumors 3Neoplasm Metastasis 2Colorectal Neoplasms 2Thoracic Neoplasms 1Solid Tumor, Adult 1Solid Tumor 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Pancreatic Neoplasms 1Noonan Syndrome 1Neoplasms by Site 1Mesothelioma 1Lung Diseases 1KRAS p.G12C Mutant Advanced Solid Tumors 1KRAS p, G12c Mutated /Advanced Metastatic NSCLC 1Hereditary Sensory and Autonomic Neuropathies 1Healthy Participants 1Carcinoma 1Bronchial Neoplasms 1Advanced/Metastatic Solid Tumors With KRAS p.G12C Mutation 1Advanced Solid Tumor 1

Interventions

Carboplatin 9Pemetrexed 7pembrolizumab 4osimertinib 3entinostat 3Gemcitabine 3zipalertinib 2selpercatinib 2pralsetinib 2durvalumab 2camrelizumab 2Paclitaxel 2Erlotinib Hydrochloride 2Cisplatin 2Bronchoscopy 2taletrectinib 1sotorasib 1repotrectinib 1patritumab 1necitumumab 1ficlatuzumab 1exemestane 1demcizumab 1cobimetinib 1ceralasertib 1atezolizumab 1alectinib 1aflibercept 1Vinorelbine 1Toll-Like Receptor 1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Lung Diseases × sotorasib × Clear all
NCT05054725 2026-01-06

Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies

Revolution Medicines, Inc.

Phase 2 Completed
47 enrolled 17 charts
Thoracic

Bronchial Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Hereditary Sensory and Autonomic Neuropathies, Respiratory Tract Diseases, Respiratory Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡